Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
3,418,112
-
Share change
-
-206,160
-
Total reported value
-
$20,426,328
-
Price per share
-
$5.98
-
Number of holders
-
33
-
Value change
-
-$1,164,861
-
Number of buys
-
12
-
Number of sells
-
16
Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q3 2017
As of 30 Sep 2017,
VTV THERAPEUTICS INC - CL A (VTVT) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,418,112 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, BlackRock Inc., SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, Alyeska Investment Group, L.P., AMERIPRISE FINANCIAL INC, Candriam Luxembourg S.C.A., STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.